Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001799812-21-000002
Filing Date
2021-02-23
Accepted
2021-02-23 16:29:00
Documents
1
Effectiveness Date
2021-02-23
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6084
  Complete submission text file 0001799812-21-000002.txt   7290
Mailing Address C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017
Business Address C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 917-334-0724
Adjuvant Global Health Technology Fund DE, L.P. (Filer) CIK: 0001799812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-358359 | Film No.: 21665940